2021
DOI: 10.1007/978-3-030-71187-0_83
|View full text |Cite
|
Sign up to set email alerts
|

A Extreme Gradient Boosting Classifier for Predicting Chronic Kidney Disease Stages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 22 publications
0
1
0
Order By: Relevance
“…The problem of predicting the CVD risk (i.e., categorizing individuals as low and high risk of CVD) is modeled as a supervised classification problem. Recent research has demonstrated the capability of decision trees (DT), random forest (RF), extreme gradient boosting (XGBoost), and deep neural networks (DNN) to accurately predict binary variables in the healthcare domain, such as disease risk 47 , heart disease 48 , and mortality risk 49 . Therefore, we employed and evaluated these four ML models for CVD risk classification.…”
Section: Methodsmentioning
confidence: 99%
“…The problem of predicting the CVD risk (i.e., categorizing individuals as low and high risk of CVD) is modeled as a supervised classification problem. Recent research has demonstrated the capability of decision trees (DT), random forest (RF), extreme gradient boosting (XGBoost), and deep neural networks (DNN) to accurately predict binary variables in the healthcare domain, such as disease risk 47 , heart disease 48 , and mortality risk 49 . Therefore, we employed and evaluated these four ML models for CVD risk classification.…”
Section: Methodsmentioning
confidence: 99%
“…The problem of predicting the CVD risk (i.e., categorizing individuals as low and high risk of CVD) is modeled as a supervised classification problem. Recent research has demonstrated the capability of decision trees (DT), random forest (RF), extreme gradient boosting (XGBoost), and deep neural networks (DNN) to accurately predict binary variables in the healthcare domain, such as disease risk [177][178][179], heart disease [180][181][182][183], and mortality risk [184][185][186]. Therefore, we employed and evaluated these four ML algorithms for CVD risk classification.…”
Section: Algorithms and Evaluationmentioning
confidence: 99%